Improving regulatory T cell-based therapy: insights into post-translational modification regulation.

Area of Science:

• Immunology
• Cell Biology

Background:

• Regulatory T (Treg) cells are crucial for immune homeostasis.
• They play significant roles in autoimmune diseases, graft-versus-host disease (GVHD), tumors, and infectious diseases.
• Treg cells employ diverse mechanisms, including cytokine suppression, cytolysis, metabolic disruption, and dendritic cell inhibition, to exert their function.

Purpose of the Study:

• To review Treg cell suppressive mechanisms.
• To summarize current evidence on how post-translational modifications (PTMs) regulate Forkhead Box P3 (FOXP3) and Treg cell function.
• To highlight the therapeutic potential of understanding PTMs in Treg cell plasticity.

Main Methods:

• Literature review of Treg cell suppressive mechanisms.
• Synthesis of current research on PTMs affecting FOXP3 and Treg cell function.
• Analysis of the role of PTMs in Treg cell plasticity and disease.

Main Results:

• Treg cells utilize multiple pathways for immune suppression.
• FOXP3, a key transcription factor, is essential for Treg cell activity.
• Various PTMs, including ubiquitination, acetylation, and phosphorylation, modulate FOXP3 activity and Treg cell function.

Conclusions:

• PTMs are critical regulators of Treg cell plasticity and function.
• Understanding PTMs offers potential therapeutic strategies for immune-related diseases.
• Targeting PTMs could lead to novel treatments for autoimmune diseases, GVHD, cancer, and infections.